A multicenter, randomized, equivalence trial of a new recombinant human chorionic gonadotropin preparation versus ovitrelle® for ovulation in women undergoing intrauterine insemination following ovarian stimulation

• Main Authors: Abha Majumdar (Author), Rekha Sachan (Author), Yogeshwar S Nandanwar (Author), Rahul V Mayekar (Author), Neelu Soni (Author), Manish R Banker (Author), Rajan S Vaidya (Author), Manjeet Arora (Author), Girish P Godbole (Author), Gautam V Daftary (Author), Ganesh H Divekar (Author), James John (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Context: A new indigenous recombinant human chorionic gonadotropin (r-hCG) has been developed in India with a comparable pharmacological profile to that of Ovitrelle® (Merck Serono). Aims: This study aims to compare the efficacy and safety of the new r-hCG with that of Ovitrelle for induction of ovu...